id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-N-4627-0001,FDA,FDA-2018-N-4627,Intent To Consider the Appropriate Classification of Hyaluronic Acid Intraarticular Products Intended for the Treatment of Pain in Osteoarthritis of the Knee Based on Scientific Evidence,Notice,Announcement,2018-12-18T05:00:00Z,2018,12,2018-12-18T05:00:00Z,,2018-12-18T13:45:44Z,2018-27351,0,0,09000064839a90fa